Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (1478 total)
-
Creator: McElroy, Anita K., Rama S. Akondy, David R. McLlwain, Han Chen, Zach Bjornson-Hooper, Nilanjan Mukherjee, Aneesh K. Mehta, Garry Nolan, Stuart T. Nichol, and Christina F. Spiropoulou.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-05-21
Description: A complete understanding of human immune responses to Ebola virus infection is limited by the availability of specimens and the requirement for biosafety level 4 (BSL-4) containment. -
Creator: National Institute of Allergy and Infectious Diseases (NIAID)
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2020-05-07
Description: This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in… -
Creator: Anfinrud, Philip, Valentyn Stadnytskyi, Christina E. Bax, and Adriaan Bax.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-05-21
Description: Aerosols and droplets generated during speech have been implicated in the person-to-person transmission of viruses, and there is current interest in understanding the mechanisms responsible for the spread of Covid-19 by these means.A response to this… -
Creator: Steven, Sanche, Lin Yen Ting, Xu Chonggang, Romero-Severson Ethan, Hengartner Nick, and Ke Ruian.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-06
Description: Severe acute respiratory syndrome coronavirus 2 is the causative agent of the 2019 novel coronavirus disease pandemic. Initial estimates of the early dynamics of the outbreak in Wuhan, China, suggested a doubling time of the number of infected… -
Creator: Solomon, Matthew D., Edward J. McNulty, Jamal S. Rana, Thomas K. Leong, Catherine Lee, Sue-Hee Sung, Andrew P. Ambrosy, Stephen Sidney, and Alan S. Go.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-05-19
Description: During the Covid-19 pandemic, reports have suggested a decrease in the number of patients presenting to hospitals because of emergency conditions such as acute myocardial infarction. -
Creator: Jordan, Rachel E., and Peymane Adab.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-05-15
Description: Despite the daily updates on number of cases, hospital admissions, and deaths around the world and the increasing number of hospital-based case series, some of the fundamental information about how severe acute respiratory syndrome coronavirus 2… -
Creator: Chung, Sheng-Chia, Rui Providencia, and Reecha Sofat.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-05-08
Description: Some researchers have hypothesized that drugs that interfere with the renin–angiotensin–aldosterone system (RAAS), including angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs), may increase susceptibility to… -
Creator: Kansagra, Akash P., Manu S. Goyal, Scott Hamilton, and Gregory W. Albers.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-05-08
Description: The effect of the Covid-19 pandemic on medical care for conditions other than Covid-19 has been difficult to quantify. Any decrease in care for patients with acute conditions such as ischemic stroke may be consequential because timely treatment may… -
Creator: Reynolds, Harmony R., Samrachana Adhikari, Claudia Pulgarin, Andrea B. Troxel, Eduardo Iturrate, Stephen B. Johnson, Anaïs Hausvater, Jonathan D. Newman, Jeffrey S. Berger, Sripal Bangalore, Stuart D. Katz, Glenn I. Fishman, Dennis Kunichoff, Yu…
Subject: Research
Item Type: Publication
Date Last Updated: 2020-05-01
Description: There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral receptor is angiotensin-converting… -
Creator: Mancia, Giuseppe, Federico Rea, Monica Ludergnani, Giovanni Apolone, and Giovanni Corrao.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-05-01
Description: A potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting–enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well studied.